Featured
Read our handpicked blogs, curated for you.
|
CMOs do not struggle to justify campaigns; they struggle to prove Marketing ROI with hard numbers the board trusts. If…
|
Pharma marketers in India know the frustration well. Campaigns stall not because the idea is weak, but because the…
|
For Indian pharma, HCP engagement is no longer about reach; it’s about relevance and measurable impact. Boards want to…
Recent releases
|
HIPAA, FDA & Beyond: How Drupal Powers Compliant Digital Ecosystems in Pharma
For pharma companies, digital isn’t a nice-to-have anymore. It’s the front line. But with every web page, every asset, every single update, you’re walking a tightrope. HIPAA, FDA, EMA, and internal…
|
Drupal vs. Commercial CMS: The Strategic Advantage for Pharma CIOs in 2025
If you're leading digital transformation in a pharma enterprise today, you're not asking whether you need a CMS; you’re asking which one will keep up with your regulatory, technical, and…
|
Why the World’s Leading Pharma Companies Are Migrating to Drupal: A 2025 Digital Transformation Playbook
Pharma doesn’t move slowly anymore. The pace of research, regulation, and global distribution has accelerated; so has the expectation for seamless, secure, compliant digital experiences. Yet too many…
|
Future-proofing Your Website: Why Drupal 11 is a Strategic Choice
Technology choices are no longer just operational decisions; they’re strategic investments. Choosing a content management system (CMS) isn't only about what your business needs today; it’s about…
